<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="t0001" orientation="portrait" position="float">
 <label>Table 1.</label>
 <caption>
  <p>Selected drug molecules obtained from virtual screening of 3CLpro against the in-house library of anti-viral drugs.</p>
 </caption>
 <!--OASIS TABLE HERE-->
 <table frame="hsides" rules="groups">
  <colgroup>
   <col width="1*"/>
   <col width="1*"/>
   <col width="1*"/>
   <col width="1*"/>
   <col width="1*"/>
   <col width="1*"/>
  </colgroup>
  <thead>
   <tr>
    <th align="left">S/No</th>
    <th align="center">Drug Bank ID</th>
    <th align="center">EBE (kcal/mol)</th>
    <th align="center">EIC (M)</th>
    <th align="center">Molecular formula</th>
    <th align="center">Chemical scheme</th>
   </tr>
  </thead>
  <tbody valign="top">
   <tr>
    <td align="left">1</td>
    <td align="center">Paritaprevir (DB09297)</td>
    <td align="center">−9.8</td>
    <td align="center">65.52 nM</td>
    <td align="center">C
     <sub>40</sub>H
     <sub>43</sub>N
     <sub>7</sub>O
     <sub>7</sub>S
    </td>
    <td align="center">
     <inline-graphic xlink:href="TBSD_A_1753577_ILG0001_C.gif" content-type="color" xmlns:xlink="http://www.w3.org/1999/xlink"/>
    </td>
   </tr>
   <tr>
    <td align="left">2</td>
    <td align="center">Raltegravir (DB06817)</td>
    <td align="center">−7.8</td>
    <td align="center">1.916 µM</td>
    <td align="center">C
     <sub>20</sub>H
     <sub>21</sub>FN
     <sub>6</sub>O
     <sub>5</sub>
    </td>
    <td align="center">
     <inline-graphic xlink:href="TBSD_A_1753577_ILG0002_C.gif" content-type="color" xmlns:xlink="http://www.w3.org/1999/xlink"/>
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn id="TF1">
   <p>EBE: Estimated Binding Free Energy; EIC: Estimated Inhibition Constant.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
